Clinicopathological factors and survival outcomes of signet-ring cell and mucinous carcinoma versus adenocarcinoma of the colon and rectum: a systematic review and meta-analysis

被引:0
作者
Michael G. Fadel
George Malietzis
Vasilis Constantinides
Gianluca Pellino
Paris Tekkis
Christos Kontovounisios
机构
[1] Chelsea and Westminster Hospital,Department of Colorectal Surgery
[2] Imperial College,Department of Surgery and Cancer
[3] Royal Marsden Hospital,Department of Colorectal Surgery
[4] Evangelistria Medical Centre,Department of General Surgery
[5] Università degli Studi della Campania ‘Luigi Vanvitelli’,Department of Advanced Medical and Surgical Sciences
来源
Discover Oncology | / 12卷
关键词
Colorectal cancer; Signet-ring cell cancer; Mucinous cancer; Survival; Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 252 条
[1]  
Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[2]  
Ma J(2018)Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue Oncotarget. 9 3432-3445
[3]  
Zou Z(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[4]  
Jemal A(2019)National trends in colorectal cancer incidence among older and younger adults in Canada JAMA Netw Open. 2 e198090-107
[5]  
Franzè E(2020)Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age JAMA Netw Open. 3 e1920407-85
[6]  
Dinallo V(2011)Is it time to lower the recommended screening age for colorectal cancer? J Am Coll Surg 213 352-105
[7]  
Rizzo A(2019)Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975–2015 JAMA 321 1933-298
[8]  
Ferlay J(2020)Colorectal cancer statistics, 2020 CA Cancer J Clin 70 145-286
[9]  
Soerjomataram I(2019)Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer BMC Cancer. 19 1071-2726
[10]  
Dikshit R(2000)Clinicopathological characteristics of mucinous carcinoma of the colon and rectum J Surg Oncol 75 103-74